Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Other Non-Current Assets: 2020-2023

Historic Other Non-Current Assets for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $3.9 million.

  • Therapeutics' Other Non-Current Assets fell 90.75% to $389,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $389,000, marking a year-over-year decrease of 90.75%. This contributed to the annual value of $3.9 million for FY2023, which is 4.09% down from last year.
  • Per Therapeutics' latest filing, its Other Non-Current Assets stood at $3.9 million for FY2023, which was down 4.09% from $4.0 million recorded in FY2022.
  • Over the past 5 years, Therapeutics' Other Non-Current Assets peaked at $4.0 million during FY2022, and registered a low of $389,000 during FY2020.
  • Over the past 3 years, Therapeutics' median Other Non-Current Assets value was $3.9 million (recorded in 2023), while the average stood at $3.6 million.
  • In the last 5 years, Therapeutics' Other Non-Current Assets spiked by 651.16% in 2021 and then dropped by 4.09% in 2023.
  • Therapeutics' Other Non-Current Assets (Yearly) stood at $389,000 in 2020, then surged by 651.16% to $2.9 million in 2021, then skyrocketed by 38.12% to $4.0 million in 2022, then dropped by 4.09% to $3.9 million in 2023.